BRIEF-Amgen and Cytokinetics say Lancet published results from Phase 2 clinical trial evaluating omecamtiv mecarbil
November 30, 2016 at 18:51 PM EST
* Says Amgen and co announced Lancet published results from a Phase 2 clinical trial evaluating omecamtiv mecarbil
